IN2014DN06964A - - Google Patents

Info

Publication number
IN2014DN06964A
IN2014DN06964A IN6964DEN2014A IN2014DN06964A IN 2014DN06964 A IN2014DN06964 A IN 2014DN06964A IN 6964DEN2014 A IN6964DEN2014 A IN 6964DEN2014A IN 2014DN06964 A IN2014DN06964 A IN 2014DN06964A
Authority
IN
India
Prior art keywords
preparation
pharmaceutically acceptable
acceptable salts
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Md Abul Kalam Azad
Prakash Bhimaji Kshirsagar
Shravan Kumar Singh
Anand Prakash Tiwari
Kaptan Singh
Mohan Prasad
Sudershan Kumar Arora
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN6964DEN2014 priority Critical patent/IN2014DN06964A/en
Publication of IN2014DN06964A publication Critical patent/IN2014DN06964A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN6964DEN2014 2012-02-02 2013-01-30 IN2014DN06964A (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN6964DEN2014 IN2014DN06964A (pl) 2012-02-02 2013-01-30

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN294DE2012 2012-02-02
IN3692DE2012 2012-11-30
PCT/IB2013/050803 WO2013114305A1 (en) 2012-02-02 2013-01-30 Process for the preparation of azilsartan medoxomil or pharmaceutically acceptable salts thereof
IN6964DEN2014 IN2014DN06964A (pl) 2012-02-02 2013-01-30

Publications (1)

Publication Number Publication Date
IN2014DN06964A true IN2014DN06964A (pl) 2015-04-10

Family

ID=47997611

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6964DEN2014 IN2014DN06964A (pl) 2012-02-02 2013-01-30

Country Status (4)

Country Link
US (1) US20150011774A1 (pl)
EP (1) EP2814826A1 (pl)
IN (1) IN2014DN06964A (pl)
WO (1) WO2013114305A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013186792A2 (en) * 2012-06-11 2013-12-19 Msn Laboratories Limited Process for the preparation of (5-methyl-2-oxo-l,3-dioxoi-4-vl)methvl 2- ethoxv-l-{[2'-(5-oxo-4,5-dihvdro-l,2,4-oxadiazol-3-vl)biphenyi-4-vl]methyl}- lh-benzimidazole-7-carboxyiate and its salts
CN104418807A (zh) * 2013-09-09 2015-03-18 天津药物研究院 一种2-乙氧基-1-[[2`-(羟基脒基)-联苯基]-4-基]甲基-1h-苯并咪唑-7-羧酸及其酯衍生物的制备方法
CN103588764B (zh) * 2013-11-11 2015-12-30 浙江永宁药业股份有限公司 阿齐沙坦酯或其盐的合成方法及其中间体
CN103588765B (zh) * 2013-11-11 2016-01-13 浙江永宁药业股份有限公司 阿齐沙坦酯或其盐的合成方法及其中间体和中间体的合成方法
CN104230909B (zh) * 2014-08-30 2018-01-09 中国人民解放军第二三○医院 一种阿齐沙坦的制备方法
CN107602546B (zh) * 2016-07-11 2022-04-22 武汉朗来科技发展有限公司 化合物的晶型及其制备方法、组合物和应用
CN107840827A (zh) * 2017-11-06 2018-03-27 江苏中邦制药有限公司 一种阿齐沙坦中间体的合成方法
CN110386928B (zh) * 2019-08-26 2021-03-26 海南皇隆制药股份有限公司 一种阿齐沙坦合成工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
CA2840818C (en) * 2011-02-08 2018-12-11 Jubilant Life Sciences Limited An improved process for the preparation of azilsartan medoxomil

Also Published As

Publication number Publication date
EP2814826A1 (en) 2014-12-24
US20150011774A1 (en) 2015-01-08
WO2013114305A1 (en) 2013-08-08

Similar Documents

Publication Publication Date Title
IN2014DN06964A (pl)
IN2015DN00598A (pl)
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
MY170713A (en) Treatment protocol of diabetes type 2
MX361499B (es) Baricitinib deuterado.
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
TW201144301A (en) Processes for preparing linezolid
MX370649B (es) Proceso para la preparacion de teneligliptina.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2013007567A (es) Procedimiento para preparar poliestereteroles.
HK1206938A1 (en) Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456--
IN2013MU03070A (pl)
IN2013MU01113A (pl)
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
IN2014DN09451A (pl)
HK1205505A1 (en) A method of preparing a highly pure potassium salt of azilsartan medoxomil
MY174153A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
IN2013MU01111A (pl)
MX2014009084A (es) Derivados de pirimidooxazocina como inhibidores de mtor.
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
PH12015502703A1 (en) Pharmaceutical compositions
WO2014170909A3 (en) Process for pomalidomide
IN2013MU01219A (pl)